Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2019 2
2020 1
2021 3
2022 11
2023 12
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Santos EJF, Farisogullari B, Dures E, Geenen R, Machado PM; EULAR taskforce on recommendations for the management of fatigue in people with inflammatory rheumatic diseases. Santos EJF, et al. Among authors: farisogullari b. RMD Open. 2023 Aug;9(3):e003350. doi: 10.1136/rmdopen-2023-003350. RMD Open. 2023. PMID: 37604639 Free PMC article.
COVID-19-associated arthritis: an emerging new entity?
Farisogullari B, Pinto AS, Machado PM. Farisogullari B, et al. RMD Open. 2022 Sep;8(2):e002026. doi: 10.1136/rmdopen-2021-002026. RMD Open. 2022. PMID: 36100294 Free PMC article. Review.
Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Farisogullari B, Santos EJF, Dures E, Geenen R, Machado PM; EULAR taskforce on recommendations for the management of fatigue in people with inflammatory rheumatic diseases; EULAR taskforce on Recommendations for the management of fatigue in people withinflammatory rheumatic diseases. Farisogullari B, et al. RMD Open. 2023 Dec 6;9(4):e003349. doi: 10.1136/rmdopen-2023-003349. RMD Open. 2023. PMID: 38056919 Free PMC article.
2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Dures E, Farisoğulları B, Santos EJF, Molto A, Feldthusen C, Harris C, Elling-Audersch C, Connolly D, Elefante E, Estévez-López F, Bini I, Primdahl J, Hoeper K, Urban M, van de Laar MAFJ, Redondo M, Böhm P, Amarnani R, Hayward R, Geenen R, Rednic S, Pettersson S, Thomsen T, Uhlig T, Ritschl V, Machado PM. Dures E, et al. Among authors: farisogullari b. Ann Rheum Dis. 2023 Nov 22:ard-2023-224514. doi: 10.1136/ard-2023-224514. Online ahead of print. Ann Rheum Dis. 2023. PMID: 38050029
Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study.
Di Matteo A, Smerilli G, Di Donato S, Liu AR, Becciolini A, Camarda F, Cazenave T, Cipolletta E, Corradini D, de Agustín JJ, Destro Castaniti GM, Di Donato E, Di Geso L, Duran E, Farisogullari B, Fornaro M, Francioso F, Giorgis P, Granel A, Hernández-Díaz C, Horvath R, Hurnakova J, Jesus D, Karadag O, Li L, Marin J, Martire MV, Michelena X, Moscioni E, Muntean L, Piga M, Rosemffet M, Rovisco J, Sahin D, Salaffi F, Saraiva L, Scioscia C, Tamas MM, Tanimura S, Venetsanopoulou A, Ventura-Rios L, Villota O, Villota-Eraso C, Voulgari PV, Vukatana G, Zacariaz Hereter J, Marzo-Ortega H, Grassi W, Filippucci E. Di Matteo A, et al. Among authors: farisogullari b. Ann Rheum Dis. 2024 Jun 12;83(7):847-857. doi: 10.1136/ard-2023-225443. Ann Rheum Dis. 2024. PMID: 38443140
Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry.
Duran E, Ozturk ZO, Bilgin E, Büyükaşık Y, Dizdar O, Yardimci GK, Farisogullari B, Özsoy Z, Ayan G, Uzun GS, Ekici M, Unaldi E, Kilic L, Akdoğan A, Karadag O, Bilgen ŞA, Kiraz S, Kalyoncu U, Ertenli AI. Duran E, et al. Among authors: farisogullari b. Rheumatol Ther. 2023 Aug;10(4):969-981. doi: 10.1007/s40744-023-00563-z. Epub 2023 Jun 9. Rheumatol Ther. 2023. PMID: 37294405 Free PMC article.
Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates.
Sandal Uzun G, Taghiyeva A, Çakır İY, Moral K, Yardımcı GK, Bölek EÇ, Farisoğulları B, Duran E, Ayan G, Özsoy Z, Ekici M, Unaldı E, Germe ŞA, Fırlatan B, Kart-Bayram GS, Bilgin E, Kılıç L, Karadağ Ö, Akdoğan A, Bilgen ŞA, Kiraz S, Ertenli AI, Kalyoncu U. Sandal Uzun G, et al. Among authors: farisogullari b. Int J Rheum Dis. 2024 Jan;27(1):e14967. doi: 10.1111/1756-185X.14967. Epub 2023 Dec 6. Int J Rheum Dis. 2024. PMID: 38057290
Comprehensive assessment and outcomes of patients with chronic periaortitis.
Yardimci GK, Ardali Düzgün S, Farisogullari B, Bölek EC, Eldem FG, Erden A, Kiliç L, Kösemehmetoglu K, Sağlam A, Peynircioğlu B, Akdoğan B, Hazirolan T, Karadag O. Yardimci GK, et al. Among authors: farisogullari b. Clin Exp Rheumatol. 2022 May;40(4):801-810. doi: 10.55563/clinexprheumatol/araba3. Epub 2022 Mar 18. Clin Exp Rheumatol. 2022. PMID: 35349413 Free article.
28 results